Pricing Log in Create free account

Capricor Therapeutics, Inc. (CAPR) vs Valneva SE Sponsored ADR (VALN)

Capricor Therapeutics, Inc. and Valneva SE Sponsored ADR are both Biotechnology companies. Capricor Therapeutics, Inc. and Valneva SE Sponsored ADR are of similar size ($572.7M and $538.4M). Capricor Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Valneva SE Sponsored ADR trades at 63.0×. Capricor Therapeutics, Inc. grew revenue faster over the last twelve months: −11.6% against −53.2%. Capricor Therapeutics, Inc. has the higher net margin (0.00% vs −12.0%) and the lower return on invested capital (−1,019.7% vs 0.00%). Across the 17 metrics below, Capricor Therapeutics, Inc. leads on 9 and Valneva SE Sponsored ADR on 8.

Valuation

Metric CAPR VALN Biotechnology median
P/E n/m 62.98 10.85
P/S 25.75 3.21 9.49
P/B 2.33 5.59 2.18
Price to free cash flow 4.38 n/m 25.85
EV/EBITDA n/m 44.98 0.70
EV/Sales 15.70 3.66 8.99
Earnings yield (24.75%) 1.59% (31.76%)
Free cash flow yield 22.83% (11.17%) (21.84%)

Profitability

Metric CAPR VALN Biotechnology median
Gross margin 100.00% 38.28% 68.51%
Operating margin 0.00% 13.56% 0.00%
Net margin 0.00% (12.01%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (73.70%) 0.00% (50.82%)
Return on assets (51.53%) 0.00% (46.04%)
Return on invested capital (1,019.73%) 0.00% 0.00%

Growth

Metric CAPR VALN Biotechnology median
Revenue growth (TTM) (11.55%) (53.16%) 6.96%
EPS growth (last fiscal year) (96.52%) (805.88%) 29.88%
Revenue growth, 5-year CAGR 85.83% 9.41% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CAPR VALN Biotechnology median
Debt to equity 0.00 2.27 0.00
Current ratio 7.35 2.16 4.84
Net debt to EBITDA 2.99 (1.15) 1.01

Dividend

Metric CAPR VALN Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric CAPR VALN Biotechnology median
Market cap 572.67m 538.44m 163.56m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack